摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4,4'-tri-O-benzyl-6,6'-di-O-((S)-2-methylarachidoyl)-3'-O-((S)-2-methylstearoyl)-2'-O-palmitoyl-α,α-D-trehalose-2-O-sulfate sodium salt | 1007886-01-2

中文名称
——
中文别名
——
英文名称
3,4,4'-tri-O-benzyl-6,6'-di-O-((S)-2-methylarachidoyl)-3'-O-((S)-2-methylstearoyl)-2'-O-palmitoyl-α,α-D-trehalose-2-O-sulfate sodium salt
英文别名
sodium;[(2R,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6R)-3-hexadecanoyloxy-6-[[(2S)-2-methylicosanoyl]oxymethyl]-4-[(2S)-2-methyloctadecanoyl]oxy-5-phenylmethoxyoxan-2-yl]oxy-6-[[(2S)-2-methylicosanoyl]oxymethyl]-4,5-bis(phenylmethoxy)oxan-3-yl] sulfate
3,4,4'-tri-O-benzyl-6,6'-di-O-((S)-2-methylarachidoyl)-3'-O-((S)-2-methylstearoyl)-2'-O-palmitoyl-α,α-D-trehalose-2-O-sulfate sodium salt化学式
CAS
1007886-01-2
化学式
C110H185O18S*Na
mdl
——
分子量
1850.72
InChiKey
UXVQETIXRFELSA-DASUDZFPSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    26.53
  • 重原子数:
    130
  • 可旋转键数:
    89
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    235
  • 氢给体数:
    0
  • 氢受体数:
    18

反应信息

  • 作为反应物:
    描述:
    3,4,4'-tri-O-benzyl-6,6'-di-O-((S)-2-methylarachidoyl)-3'-O-((S)-2-methylstearoyl)-2'-O-palmitoyl-α,α-D-trehalose-2-O-sulfate sodium salt 在 palladium on activated charcoal 氢气 作用下, 以 甲醇二氯甲烷 为溶剂, 以53%的产率得到6,6'-di-O-((S)-2-methylarachidoyl)-3'-O-((S)-2-methylstearoyl)-2'-O-palmitoyl-α,α-D-trehalose-2-O-sulfate sodium salt
    参考文献:
    名称:
    Synthetic Studies toward Mycobacterium tuberculosis Sulfolipid-I
    摘要:
    [GRAPHICS]Sulfolipid-I (SL-I) is an abundant metabolite found in the cell wall of Mycobacterium tuberculosis that is comprised of a trehalose 2-sulfate core modified with four fatty acyl substituents. The correlation of its abundance with the virulence of clinical isolates suggests a role for SL-I in pathogenesis, although its biological functions remain unknown. Here we describe the synthesis of a SL-I analogue bearing unnatural lipid substituents. A key feature of the synthesis was application of an intramolecular aglycon delivery reaction to join two differentially protected glucose monomers, one prepared with a novel alpha-selective glycosylation. The route developed for the model compound can be readily extended to the synthesis of native SL-I as well as additional analogues for use in the investigation of SL-I's functions.
    DOI:
    10.1021/jo702032c
点击查看最新优质反应信息